Why the study?
To evaluate antithrombotic therapy and its impact on long-term prognosis in patients with type 1 myocardial infarction and preexisting atrial fibrillation.
Does incorrect use or discontinuation of anticoagulants increase the risk of stroke and cardiovascular events in patients with type 1 myocardial infarction and preexisting atrial fibrillation?
Observational (n=100)
No
Does incorrect use or discontinuation of anticoagulants increase the risk of stroke and cardiovascular events in patients with type 1 myocardial infarction and preexisting atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Aim. To study antithrombotic therapy (ATT) in patients with myocardial infarction (MI) type 1 and preexisting atrial fibrillation (AF), effect of ATT on prognosis. Material and methods. 100 patients with type 1 MI and preexisting AF were selected. The exclusion criterion was severe concomitant pathology. Results. Only 13.0% of AF patients took anticoagulants (AC) adequately before hospitalization. 94.0% of patients in hospital and 80.5% at discharge were prescribed triple ATT at least for 1 month with transition to dual ATT (AC + disaggregant) for 12 months. ACs were prescribed in hospital in 100.0% of cases, at discharge in 93.1%. After 1 year 8.4% of patients stopped taking ACs, after 2.31.9 years 15.7%. The incidence of ischemic and hemorrhagic events didnt differ in patients with different regimens of ATT (double/triple) and types of AСs (vitamin K antagonists/non-vitamin K antagonist ACs). In the long-term period patients, who took ACs incorrectly or stopped taking ACs, had increased risks of stroke (OR 9.580; 95% CI 1.15379.599, p=0.0365); combined endpoint: recurrent MI + stroke + cardiovascular mortality (OR 2.556; 95% CI 1.1045.918, p=0.0284). Сonclusion. Patients with preexisting AF had a low adherence to ACs prior to MI. It increased after hospitalization and decreased during follow-up. In the long-term period patients, who took ACs incorrectly or stopped taking ACs, had significantly increased risks of stroke, combined endpoint. There were no differences in the prognosis depending on the type of ACs, the regimens of ATT administered in accordance with ischemic and hemorrhagic risks.
No takes yet. Share an insight, caveat, or question.
Соловьева et al. (2021) conducted an observational in Myocardial infarction type 1 and preexisting atrial fibrillation (n=100). Incorrect intake or discontinuation of anticoagulants vs. Adequate intake of anticoagulants was evaluated on Combined endpoint (recurrent MI, stroke, and cardiovascular mortality) (OR 2.556, 95% CI 1.104-5.918, p=0.0284).
Synapse has enriched 10 related papers. Consider them for comparative context: